Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies.

Sievers, Sören; Wieschowski, Susanne; Strech, Daniel

Sievers, Sören; Wieschowski, Susanne; Strech, Daniel.

Sievers S; Hannover Medical School, Institute for Ethics, History, and Philosophy of Medicine, Hannover, 30625, Germany.
Wieschowski S; Hannover Medical School, Institute for Ethics, History, and Philosophy of Medicine, Hannover, 30625, Germany.
Strech D; Hannover Medical School, Institute for Ethics, History, and Philosophy of Medicine, Hannover, 30625, Germany.

Br J Clin Pharmacol ; 87(7): 2723-2731, 2021 07.

Article en En | MEDLINE | ID: mdl-33068032

Asunto(s)

Evaluación de Resultado en la Atención de Salud; Folletos; Humanos; Estudios Prospectivos

Palabras clave

bioethics; drug development; drug safety; research ethics; translational research

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Folletos / Evaluación de Resultado en la Atención de Salud Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google